– La Comisión Europea aprueba ORSERDU® (elacestrant) de Menarini Group para el tratamiento de pacientes con cáncer de mama ER+, HER2- localmente avanzado o metastásico con una mutación activadora ESR1 · Cada año en Europa, más de 550.000 pacientes son diagnosticadas con cáncer de mama, de…
Month: September 2023
DUBLIN, Sept. 21, 2023 /PRNewswire/ — The “Global and China Automotive Gateway Industry Report, 2023” report has been added to ResearchAndMarkets.com’s offering. Automotive gateway research: integrated gateways have become an important trend in zonal architecture. Automotive gateway is a…
Future Market Insights presents an in-depth analysis of the Industrial Fractional Horsepower Motors Market from 2023 to 2033. From the automotive sector to the coffee industry, these motors are poised to be the unsung heroes, driving efficiency and innovation across various end-use…
WOONSOCKET, R.I., Sept. 21, 2023 /PRNewswire/ — CVS Health Corporation (NYSE: CVS) has appointed Michael F. Mahoney, Chairman and CEO of Boston Scientific Corporation (NYSE: BSX), a global medical technology leader, to serve on the Board of Directors (the “Board”) of CVS Health,…
ZHENGZHOU, China, Sept. 21, 2023 /PRNewswire/ — The 2023 Conference on Diamond Industry is being held in Zhengzhou City, Henan Province, from September 18th to 22nd. With the motto of “Gathering the advantages of the industrial chain and co-creating the future of the diamond material”,…
SHANGHAI, Sept. 21, 2023 /PRNewswire/ — During HUAWEI CONNECT 2023, Huawei held a distribution business session titled “HUAWEI eKit, Digitalization for Success”, outlined its approach to the distribution business: focus on distribution partners (DPs), stay subcontractor-centred, and help…
KUWAIT CITY, Kuwait, Sept. 21, 2023 /PRNewswire/ — Building on the momentum of last year’s groundbreaking summit of technology, finance, and digital banking innovations /MoneyTech returns to Kuwait on November 12th. Registration is free on aljaridasummits.com. Aljarida General Manager Mr….
Jedes Jahr wird in Europa bei mehr als 550.000 Patienten Brustkrebs diagnostiziert, von denen 70 % Östrogenrezeptor (ER)-positiv sind¹; in Europa sterben jährlich mehr als 147.000 Brustkrebspatienten an dieser Erkrankung² ORSERDU ist die erste Behandlungsmethode speziell für Patienten mit…
BEIJING, Sept. 21, 2023 /PRNewswire/ — Gravitas Education Holdings Inc. (the “Company”) (NYSE: GEHI), a leading early childhood education service provider in China, today announced that the Company’s board of directors (the “Board”) approved a special cash dividend in an amount ranging…
CHANDLER, Ariz., Sept. 21, 2023 /PRNewswire/ — Viavi Solutions Inc. (VIAVI) (NASDAQ: VIAV) today unveiled Observer Sentry, Software-as-a-Service-based Threat Exposure Management providing SecOps, DevOps, and cloud architects much-needed threat visibility into ever-changing AWS…